Establishing Efficacy of Human Products Using Animals
- 15 June 2010
- journal article
- review article
- Published by SAGE Publications in Veterinary Pathology
- Vol. 47 (5), 774-778
- https://doi.org/10.1177/0300985810372506
Abstract
In 2002, the US Food and Drug Administration issued regulations to allow the approval of human drugs and biological products based on animal efficacy studies when human efficacy studies would be unethical or not feasible. These regulations are intended to assist in the approval process for products aimed at preventing or treating human diseases caused by nuclear, radiological, biological, and chemical agents that have the potential to harm a significant percentage of the US population. This article discusses the criteria that must be met to use the Animal Rule to demonstrate efficacy in place of human clinical trials.Keywords
This publication has 7 references indexed in Scilit:
- Progression of primary pneumonic plague: A mouse model of infection, pathology, and bacterial transcriptional activityProceedings of the National Academy of Sciences, 2005
- BiodefensePublished by Informa UK Limited ,2005
- Rabbit and Nonhuman Primate Models of Toxin-Targeting Human Anthrax VaccinesMicrobiology and Molecular Biology Reviews, 2004
- The history and threat of biological warfare and terrorismEmergency Medicine Clinics of North America, 2002
- The Anthrax Vaccine. Is It Safe? Does It Work?Published by Defense Technical Information Center (DTIC) ,2002
- Strengthening National Preparedness for Smallpox: an UpdateEmerging Infectious Diseases, 2001
- Immune Response to Yersinia Outer Proteins and Other Yersinia pestis Antigens after Experimental Plague Infection in MiceInfection and Immunity, 1999